Healthcare & Life Sciences
Cytovale
United Stateswww.cytovale.com
Cytovale is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
activeseries-c-plus
series-c-plus
Stage
2016
Founded
2
Investors
About Cytovale
Cytovale is a company founded in 2016 headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Cytovale develops rapid blood-based diagnostic tests for critical care, focusing on identifying sepsis and other acute conditions by measuring immune cell responses at the single-cell level using advanced cytometry and microfluidics technologies.
Explore Cytovale's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.